Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Sex Transm Dis. 2012 Mar;39(3):191–194. doi: 10.1097/OLQ.0b013e3182401a2f

The impact of HIV seroadaptive behaviours on sexually transmissible infections in HIV-negative homosexual men in Sydney, Australia

Fengyi Jin 1,2, Garrett P Prestage 1, David J Templeton 1,3, I Mary Poynten 1, Basil Donovan 1,4, Iryna Zablotska 1, Susan C Kippax 5, Adrian Mindel 2, Andrew E Grulich 1
PMCID: PMC3282017  NIHMSID: NIHMS342155  PMID: 22337105

Abstract

Background

HIV seroadaptive behaviours such as serosorting and strategic positioning are being increasingly practised by homosexual men, however, their impact on sexually transmissible infections (STIs) is unclear.

Methods

Participants were 1,427 initially HIV-negative men enrolled from 2001 to 2004 and followed to June 2007. Participants were tested annually for anal and urethral gonorrhoea and chlamydia, herpes simplex virus, and syphilis. In addition, they reported diagnoses of these conditions, and of genital and anal warts between annual visits, and sexual risk behaviours.

Results

Compared with men who reported no unprotected anal intercourse (UAI), serosorting was associated with an increased risk of urethral (HR=1.97, 95% CI 1.43–2.72) and anal (HR=1.62, 95% CI 1.11–2.36) chlamydia. Compared with men who reported UAI with HIV non-concordant partners, men who practised serosorting had significantly lower risk of incident syphilis (HR=0.21, 95% CI 0.05–0.81) and urethral gonorrhoea (HR=0.61, 95% CI 0.39–0.96). Compared with men who reported no UAI, strategic positioning was associated with an increased risk of urethral gonorrhoea (HR=1.72, 95% CI 1.05–2.83) and chlamydia (HR=2.22, 95% CI 1.55–3.18). Compared with men who reported receptive UAI, the incidence of anal gonorrhoea (HR=0.38, 0.20–0.74) and chlamydia (HR= 0.44, 95% CI 0.27–0.69) was significantly lower in those who practised strategic positioning.

Conclusion

For men who reported seopadaptive behaviours, rates of some bacterial STIs were higher than in men who reported no UAI. However, rates were lower than for men who reported higher HIV risk behaviours.

Keywords: Cohort study, STI, Homosexuality, male, HIV seroadaptive behaviour, Australia

Introduction

Seroadaptive behaviours such as serosorting and strategic positioning are sexual behaviours employed by homosexual men to reduce the risk of transmitting or acquiring HIV while engaging in unprotected anal intercourse (UAI) [13]. For an HIV-negative man, serosorting means restricting any UAI to sexual partners who are also HIV-negative, and strategic positioning means restricting UAI to taking the insertive role only. These risk reduction behaviours are fairly common among homosexual men [4], with recently reported increases in some developed countries [5]. Compared with other forms of UAI, these behaviours have been demonstrated to offer partial protection against HIV transmission [6]. Little has been published on the impact of these behaviours on other sexually transmissible infections (STIs) [7], though there is a suggestion that serosorting among HIV-positive men has resulted in increased STI transmission [1, 8, 9]. To address this issue, we examined the associations between serosorting, strategic positioning and the incidence of a range of STIs in a cohort of HIV-negative homosexual men in Sydney, Australia.

Methods

Participants were from the Health in Men (HIM) study which recruited from a wide range of community settings from June 2001 to December 2004. Participants were followed up to June 2007 at six-monthly intervals [10]. Comprehensive sexual health screening was offered, including syphilis serology, gonorrhoea and chlamydia testing from the urethra and anus using nucleic acid amplification and herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) and syphilis serology. In addition, self reported diagnoses of these conditions between annual visits, and of genital and anal warts in the previous 12 months were collected [11]. Signed informed consent was obtained from all participants. Ethics approval was granted by the Human Research Ethics Committee at the University of New South Wales.

Both serosorting and strategic positioning were defined behaviourally [6]. Participants who reported 1) UAI in the last six months and 2) that all UAI episodes were with partners known to be HIV-negative were defined as practising serosorting. Participants who reported 1) UAI in the last six months and 2) that all UAI episodes were in the insertive position were defined as practising strategic positioning.

Statistical analyses were performed using STATA 10.1 (STATA Corporation, College Station, TX). Univariate Cox regressions were performed to calculate the hazard ratio (HR) of incident STIs in those who fulfilled the definition of practising serosorting compared with men reporting no UAI, and with those reporting non-seroconcordant UAI (UAI with HIV status unknown or HIV-positive partners) in the past 6 months. For men who fulfilled the definition of practising strategic positioning, HRs were calculated comparing STI incidence in this group with men reporting no UAI, and with men reporting at least one or more episodes of receptive UAI in the last 6 months. As the number of sexual partners in the last six months and age were almost universally associated with the range of STIs examined [1012], these two factors were included in multivariate Cox regressions when the univariate p value was less than 0.10.

Results

Between June 2001 and December 2004, 1427 initially HIV-negative men were recruited, and they were followed to June 2007. The median age at enrolment was 35 years (range: 18–75).

Serosorting

In comparison with men who did not report UAI, serosorting was associated with an increased risk of urethral chlamydia (HR=1.75, 95% CI 1.27–2.41). There were also borderline elevated risks of anal chlamydia (HR=1.41, 95% CI 0.97–2.05) and of incident HSV-1 infection (HR=1.68, 95% CI 0.99–2.86). After adjustment for age and number of sexual partners, the increased risk remained significant for both urethral (adjusted HR=1.97, 95% CI 1.43–2.72) and anal (adjusted HR=1.62, 95% CI 1.11–2.36, Table 1) chlamydia.

Table 1.

The impact of serosorting and strategic positioning on sexually transmissible infections in the Health in Men study

n Incidence Per 100 PY Univariate analysis Multivariate analysis1

HR 95% CI P value Adjusted HR 95% CI P value
Serosorting
vs. No UAI
Bacterial STIs
Urethral chlamydia 0.001 <0.001
 Serosorting 99 6.06 1.75 1.27–2.41 1.97 1.43–2.72
 No UAI 61 3.56 1 --- 1 ---
Anal chlamydia 0.072 0.013
 Serosorting 64 3.95 1.41 0.97–2.05 1.62 1.11–2.36
 No UAI 48 2.80 1 --- 1 ---
Viral STIs
HSV-1 0.057 0.059
 Serosorting 31 9.09 1.68 0.99–2.86 1.68 0.98–2.87
 No UAI 24 5.51 1 --- 1 ---
vs. Non-concordant UAI (Non SS)
Bacterial STIs
Syphilis 0.011 0.023
 Serosorting 3 0.18 0.19 0.05–0.68 0.21 0.05–0.81
 Non SS 10 1.00 1 --- 1 ---
Urethral gonorrhoea <0.001 0.033
 Serosorting 35 2.15 0.41 0.27–0.63 0.61 0.39–0.96
 Non SS 56 5.52 1 --- 1 ---
Anal gonorrhoea 0.004 0.090
 Serosorting 39 2.40 0.54 0.35–0.82 0.67 0.43–1.06
 Non SS 46 4.55 1 --- 1 ---
Urethral chlamydia <0.001 0.136
 Serosorting 99 6.06 0.55 0.42–0.72 0.80 0.60–1.07
 Non SS 114 11.34 1 --- 1 ---
Anal chlamydia <0.001 0.109
 Serosorting 64 3.95 0.51 0.37–0.71 0.75 0.53–1.07
 Non SS 80 7.93 1 --- 1 ---
Strategic positioning
vs. No UAI
Bacterial STIs
Urethral gonorrhoea 0.008 0.032
 Strategic positioning 28 4.11 1.95 1.19–3.20 1.72 1.05–2.83
 No UAI 36 2.10 1 --- 1 ---
Urethral chlamydia <0.001 <0.001
 Strategic positioning 59 8.71 2.46 1.72–3.53 2.22 1.55–3.18
 No UAI 61 3.56 1 --- 1 ---
vs. Receptive UAI
Bacterial STIs
Anal gonorrhoea 0.005 0.004
 Strategic positioning 10 1.48 0.39 0.20–0.75 0.38 0.20–0.74
 Receptive UAI 75 3.83 1 --- 1 ---
Anal chlamydia 0.003 <0.001
 Strategic positioning 21 3.10 0.49 0.31–0.78 0.44 0.27–0.69
 Receptive UAI 123 6.30 1 --- 1 ---

UAI: unprotected anal intercourse; STI: sexually transmissible infection;

Bacterial STIs examined included syphilis, gonorrhoea (urethral and anal) and chlamydia (urethral and anal); Viral STIs examined included herpes simplex virus types 1 and 2, genital and anal warts.

1

adjusted for age and number of sexual partners reported in the last 6 months.

In comparison with men who reported non-seroconcordant UAI, the risk of all bacterial STIs examined was significantly reduced in those who practised serosorting, including syphilis (HR=0.19, 95% CI 0.05–0.68), urethral gonorrhoea (HR=0.41, 95% CI 0.27–0.63), anal gonorrhoea (HR=0.54, 95% CI 0.35–0.82), urethral chlamydia (HR=0.55, 95% CI 0.42–0.72), and anal chlamydia (HR=0.51, 95% CI 0.37–0.71). After adjustment for age and number of sexual partners, the association remained significant for syphilis (adjusted HR=0.21, 95% CI 0.05–0.81) and urethral gonorrhoea (adjusted HR=0.61, 95% CI 0.39–0.96) and was of borderline significance for anal gonorrhoea (adjusted HR=0.67, 95% CI 0.43–1.06, Table 1).

Strategic positioning

In comparison with men who did not report UAI, the risk of urethral bacterial STIs including gonorrhoea (HR=1.95, 95% CI 1.19–3.20) and chlamydia (HR=2.46, 95% CI 1.72–3.52) was significantly increased in those who practised strategic positioning. Risk of viral STIs was not increased. After adjustment for age and number of sexual partners, the increased risk of urethral gonorrhoea (adjusted HR=1.72, 95% CI 1.05–2.83) and urethral chlamydia (adjusted HR=2.22, 95% CI 1.55–3.18, Table 1) remained significant.

In comparison with men who engaged in receptive UAI, the risk of anal bacterial STIs was significantly reduced in those who practised strategic positioning, including anal gonorrhoea (HR=0.39, 95% CI 0.20–0.75) and anal chlamydia (HR=0.49, 95% CI 0.31–0.78). Strategic positioning had no impact on the risk of viral STIs. After adjustment for age and number of sexual partners, the reduced risk of anal gonorrhoea (adjusted HR=0.38, 95% CI 0.20–0.74) and anal chlamydia (adjusted HR=0.44, 95% CI 0.27–0.69, Table 1) remained significant.

Discussion

Seroadaptive behaviours were associated with STI risk that was generally intermediate between the lower risk associated with no UAI, and the higher risk associated with higher HIV risk forms of UAI. Compared with men who reported no UAI, serosorting was associated with a significantly increased risk of chlamydia, and, unsurprisingly, strategic positioning was associated with a significantly increased risk of urethral bacterial infections. Conversely, compared with men who reported higher HIV risk UAI, serosorters were at a significantly lower risk of syphilis and gonorrhoea, and those who practised strategic positioning had a reduced risk of both anal gonorrhoea and anal chlamydia.

For an HIV-negative gay man, serosorting means having UAI only with other HIV- negative men. Among homosexual men, most STIs are more prevalent in HIV-positive men [13]. Thus it is not surprising that HIV-negative serosorters have STI rates that are lower than men who report UAI with HIV-positive partners. The difference in rates of STIs between HIV-positive and HIV-negative men is most marked for syphilis [14]. While serosorting among HIV-negative men appears to offer some protection against syphilis, serosorting among HIV-positive men is likely to be particularly high risk for transmission of syphilis [15].

For an HIV-negative gay man, strategic positioning means only adopting the insertive position in UAI. Thus our finding of increased incidence of certain urethral STIs compared with those who report no UAI, but decreased incidence of anal STIs compared with those who report receptive UAI makes intuitive sense.

In summary, among HIV negative men who reported UAI, serosorting and strategic positioning appeared to have some protective effect against certain STIs, but they were associated with higher risk of STIs than men who reported no UAI. Our findings need to be interpreted in the context of the high levels of HIV and STI testing among homosexual men in Sydney [16, 17]. In settings where HIV and STI testing are less frequent the protective effect against some STIs reported here may not be demonstrated. These results show that HIV risk reduction behaviours may offer limited protection against some STIs among men who report UAI, but that consistent condom use provides more reliable protection.

Short summary.

HIV seroadaptive behaviours were associated with increased rates of sexually transmissible infections compared with men who reported no unprotected anal intercourse in a cohort of HIV-negative homosexual men in Sydney.

Acknowledgements

The authors thank all the participants, the dedicated pH and HIM study team and the participating doctors and clinics. We also thank Ms. Janette Taylor from the Westmead Millennium Institute for performing the herpes simplex virus testing, and Mr. Philip Cunningham and Mr. Leon McNally from SydPath for performing the gonorrhoea and chlamydia testing and the confirmatory NGpapLC testing.

Source of support: The Kirby Institute and the National Centre in HIV Social Research are funded by the Australian Government Department of Health and Ageing. The Health in Men Cohort study was funded by the National Institutes of Health, a component of the U.S. Department of Health and Human Services (NIH/NIAID/DAIDS: HVDDT Award N01-AI-05395), the National Health and Medical Research Council in Australia (NHMRC, Project grant # 400944), the Australian Government Department of Health and Ageing (Canberra), and the New South Wales Health Department (Sydney). The Positive Health Cohort study was funded by the Australian Government Department of Health and Ageing (Canberra) and the New South Wales Health Department (Sydney). The views expressed in this publication do not necessarily represent the position of the Australian Government.

The herpes testing was funded by GlaxoSmithKline. The testing materials for gonorrhoea and chlamydia were provided by Becton Dickinson Pty Ltd.

FJ is supported by a Post-doctoral Training Fellowship (#571402) from the NHMRC. AEG is supported by a NHMRC Principal Research Fellowship (#568819). BD is supported by a NHMRC Practitioner Fellowship (#568613). IMP is supported by a NHMRC Training Fellowship (#1016307). DJT is supported by a NHMRC Training Fellowship (#1013353).

Footnotes

Competing Interest: None declared

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Hart GJ, Elford J. Sexual risk behaviour of men who have sex with men: emerging patterns and new challenges. Curr Opin Infect Dis. 2010;23:39–44. doi: 10.1097/QCO.0b013e328334feb1. [DOI] [PubMed] [Google Scholar]
  • 2.Crepaz N, Marks G, Liau A, et al. Prevalence of unprotected anal intercourse among HIV-diagnosed MSM in the United States: a meta-analysis. AIDS. 2009;23:1617–1629. doi: 10.1097/QAD.0b013e32832effae. [DOI] [PubMed] [Google Scholar]
  • 3.McFarland W, Chen YH, Raymond HF, et al. HIV seroadaptation among individuals, within sexual dyads, and by sexual episodes, men who have sex with men, San Francisco, 2008. AIDS Care. 2011;23:261–268. doi: 10.1080/09540121.2010.507748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Eaton LA, Kalichman SC, O'Connell DA, et al. A strategy for selecting sexual partners believed to pose little/no risks for HIV: serosorting and its implications for HIV transmission. AIDS Care. 2009;21:1279–1288. doi: 10.1080/09540120902803208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Mao L, Crawford JM, Hospers HJ, et al. “Serosorting” in casual anal sex of HIV-negative gay men is noteworthy and is increasing in Sydney, Australia. AIDS. 2006;20:1204–1206. doi: 10.1097/01.aids.0000226964.17966.75. [DOI] [PubMed] [Google Scholar]
  • 6.Jin F, Crawford J, Prestage GP, et al. Unprotected anal intercourse, risk reduction behaviours, and subsequent HIV infection in a cohort of homosexual men. AIDS. 2009;23:243–252. doi: 10.1097/QAD.0b013e32831fb51a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Golden MR, Stekler J, Hughes JP, et al. HIV serosorting in men who have sex with men: is it safe? J Acquir Immune Defic Syndr. 2008;49:212–218. doi: 10.1097/QAI.0b013e31818455e8. [DOI] [PubMed] [Google Scholar]
  • 8.Truong HM, Kellogg T, Klausner JD, et al. Increases in sexually transmitted infections and sexual risk behaviour without a concurrent increase in HIV incidence among men who have sex with men in San Francisco: a suggestion of HIV serosorting? Sex Transm Infect. 2006;82:461–466. doi: 10.1136/sti.2006.019950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Williamson LM, Dodds JP, Mercey DE, et al. Sexual risk behaviour and knowledge of HIV status among community samples of gay men in the UK. AIDS. 2008;22:1063–1070. doi: 10.1097/QAD.0b013e3282f8af9b. [DOI] [PubMed] [Google Scholar]
  • 10.Jin F, Prestage GP, Mao L, et al. Transmission of herpes simplex virus types 1 and 2 in a prospective cohort of HIV-negative gay men: the Health in Men study. J Infect Dis. 2006;194:561–570. doi: 10.1086/506455. [DOI] [PubMed] [Google Scholar]
  • 11.Jin F, Prestage GP, Kippax SC, et al. Risk factors for genital and anal warts in a prospective cohort of HIV-negative homosexual men: the HIM study. Sex Transm Dis. 2007;34:488–493. doi: 10.1097/01.olq.0000245960.52668.e5. [DOI] [PubMed] [Google Scholar]
  • 12.Jin F, Prestage GP, Mao L, et al. Incidence and risk factors for urethral and anal gonorrhoea and chlamydia in a cohort of HIV-negative homosexual men: the Health in Men Study. Sex Transm Infect. 2007;83:113–119. doi: 10.1136/sti.2006.021915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Jin F, Prestage GP, Zablotska I, et al. High rates of sexually transmitted infections in HIV positive homosexual men: data from two community based cohorts. Sex Transm Infect. 2007;83:397–399. doi: 10.1136/sti.2007.025684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Jin F, Prestage GP, Zablotska I, et al. High incidence of syphilis in HIV-positive homosexual men: data from two community-based cohort studies. Sex Health. 2009;6:281–284. doi: 10.1071/SH09060. [DOI] [PubMed] [Google Scholar]
  • 15.Dougan S, Evans BG, Elford J. Sexually transmitted infections in Western Europe among HIV-positive men who have sex with men. Sex Transm Dis. 2007;34:783–790. doi: 10.1097/01.olq.0000260919.34598.5b. [DOI] [PubMed] [Google Scholar]
  • 16.Prestage GP, Jin F, Zablotska IB, et al. Trends in HIV testing among homosexual and bisexual men in eastern Australian states. Sexual Health. 2008;5:119–123. doi: 10.1071/sh07081. [DOI] [PubMed] [Google Scholar]
  • 17.Zablotska IB, Imrie J, Bourne C, et al. Improvements in sexual health testing among gay men in Sydney, Australia, 2003–2007. Int J STD AIDS. 2008;19:758–760. doi: 10.1258/ijsa.2008.008193. [DOI] [PubMed] [Google Scholar]

RESOURCES